Skip to content

Interactions of Xadago: Exploring combinations with alcohol, supplements, and other substances

Interactions of Xadago with alcohol, supplements, and other substances

Interactions of Xadago with alcohol, supplements, and other substances
Interactions of Xadago with alcohol, supplements, and other substances

Interactions of Xadago: Exploring combinations with alcohol, supplements, and other substances

In the treatment of symptoms associated with Parkinson's disease, it is essential to exercise caution when combining the medication Safinamide (Xadago) with Selective Serotonin Reuptake Inhibitors (SSRIs).

Safinamide, a brand-name oral tablet, is primarily used for treating symptoms of Parkinson's disease in adults who take levodopa/carbidopa. It works by inhibiting monoamine oxidase B (MAO-B), an enzyme that breaks down certain brain chemicals. This action can potentially increase serotonin levels in the brain.

SSRIs, such as fluoxetine (Prozac) and sertraline (Zoloft), increase serotonin by blocking its reuptake, a process that helps regulate its levels in the brain. When used together, the combined effect may increase the risk of serotonin syndrome, a serious condition characterised by symptoms such as agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, and other potentially life-threatening complications.

To minimise these risks, it is advisable to combine Safinamide with SSRIs at the lowest effective dose of the SSRI. Close monitoring for symptoms of serotonin syndrome is also recommended when using these medications concurrently.

In addition to SSRIs, there are several other substances and medications that may interact with Safinamide, potentially causing unexpected effects or increased risks. These include tryptophan or 5-HTP supplements, St. John's wort, alcohol, opioid drugs such as codeine and hydrocodone, dextromethorphan, and certain antipsychotics.

It is crucial to inform your doctor and pharmacist about any medications you are currently taking, including over-the-counter drugs and supplements, as well as any medical conditions you may have, such as liver problems, high blood pressure, or mental health conditions.

While taking Safinamide, it is usually safe to take acetaminophen (Tylenol) or nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. However, it is essential to consult your doctor before making any changes to your medication regimen.

In summary, when using Safinamide (Xadago), it is crucial to exercise caution, especially when combined with SSRIs. Close monitoring, using the lowest effective SSRI dosage, and open communication with your healthcare providers are key to mitigating interaction risks.

  1. The neurological disease Parkinson's necessitates the consideration of potential drug interactions, like the combination of Safinamide (Xadago) with Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine (Prozac) or sertraline (Zoloft), which can lead to serotonin syndrome, a severe medical-condition with symptoms such as agitation and rapid heart rate.
  2. Health-and-wellness practitioners suggest minimizing these risks by combining Safinamide with SSRIs at the lowest effective dose, as well as monitoring closely for serotonin syndrome symptoms when using them concurrently.
  3. Furthermore, there are various substances and medications, such as tryptophan or 5-HTP supplements, antidepressants, antipsychotics, opioid drugs, and alcohol, that may interact with Safinamide, causing unintended effects or increased risks.
  4. To avoid such interactions, it's essential to inform your medical providers about any medications you're taking, including over-the-counter drugs or supplements, and any pre-existing medical-conditions like liver problems, high blood pressure, or mental health conditions.
  5. Although taking Safinamide, it is usually safe to take acetaminophen (Tylenol) or nonsteroidal anti-inflammatory drugs (NSAIDs), consultation with your healthcare provider before making any medication changes remains imperative.

Read also:

    Latest